Market revenue in 2022 | USD 2.3 million |
Market revenue in 2030 | USD 6.7 million |
Growth rate | 13.9% (CAGR from 2022 to 2030) |
Largest segment | Radiology |
Fastest growing segment | Immunotherapy |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Surgery, Radiology, Chemotherapy, Immunotherapy |
Key market players worldwide | Zoetis Inc Class A, Karyopharm Therapeutics Inc, Varian, Accuray Inc, PetCure Oncology, Boehringer Ingelheim, Elanco Animal Health Inc, One Health Group, Regeneus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary oncology market will help companies and investors design strategic landscapes.
Radiology was the largest segment with a revenue share of 30.43% in 2022. Horizon Databook has segmented the Mexico veterinary oncology market based on surgery, radiology, chemotherapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico veterinary oncology market, including forecasts for subscribers. This country databook contains high-level insights into Mexico veterinary oncology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account